ONB: Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System
What it covers
Reconstitute and transfer antineoplastic and other hazardous drugs in healthcare setting indicated to reduce exposure of healthcare personnel to chemotherapy agents in healthcare setting.
FDA’s definition of product code ONB, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K251722 | ProSeal Transfer Injector (421120, 421130, 421140) | Epic Medical Pte. , Ltd. | Dec 5, 2025 | Special |
| K253033 | Chemfort® 28-day 20 mm Vial Adaptor and 13 mm Convertor | Simplivia Healthcare , Ltd. | Oct 21, 2025 | Special |
| K250059 | BD PhaSeal Optima Connecting Set (C83-O); BD PhaSeal Optima Spike Set (C180-O) | Becton, Dickinson and Company | Sep 12, 2025 | Traditional |
| K251411 | Chemfort Female Luer Lock Adaptor | Simplivia Healthcare , Ltd. | Aug 5, 2025 | Traditional |
| K251340 | ProSeal Bag Spike with Additive Port (423370ST, 423370) | Epic Medical Pte. , Ltd. | May 29, 2025 | Special |
| K243976 | ZeroClear Bag Access (423100) | Epic Medical Pte. , Ltd. | Jan 22, 2025 | Special |
| K240517 | ProSeal Vented Universal Vial Adaptor | Epic Medical Pte. , Ltd. | Dec 26, 2024 | Traditional |
| K241988 | ProSeal Closed System Bag Access | Epic Medical Pte. , Ltd. | Oct 23, 2024 | Traditional |
| K241735 | ProSeal In Line Pump Set (423850) | Epic Medical Pte. , Ltd. | Oct 10, 2024 | Special |
| K241823 | ToxiSeal Vial Adaptor | Epic Medical Pte. , Ltd. | Aug 30, 2024 | Special |
Clearances by year
41 ONB 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 6 | 60 |
| 2024 | 8 | 102 |
| 2023 | 3 | 175 |
| 2022 | 1 | 904 |
| 2021 | 3 | 277 |
| 2020 | 3 | 213 |
| 2019 | 1 | 266 |
| 2018 | 6 | 249 |
| 2017 | 2 | 94 |
| 2015 | 3 | 235 |
| 2014 | 2 | 154 |
| 2013 | 3 | 58 |
Who submits
13 applicants cleared a ONB device since 2011. 39% of the clearances went to applicants in United States, then Singapore (29%), Israel (27%) and China (2%). By type: Traditional 66%, Special 29% and Abbreviated 5%.
| Applicant | Clearances since 2011 |
|---|---|
| Epic Medical Pte. , Ltd. | 12 |
| Simplivia Healthcare , Ltd. | 6 |
| Becton, Dickinson and Company | 4 |
| Equashield Medical , Ltd. | 4 |
| Icu Medical, Inc. | 3 |
| Teva Medical Ltd., Migada Plant | 3 |
| Becton, Dickinson & CO | 2 |
| J & J Solutions, Inc. D/B/A/ Corvida Medical | 2 |
How FDA classifies it
Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
From 21 CFR 880.5440. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 880.5440 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent ONB clearances declared.
Ask about ONB
Questions about ONB
What is FDA product code ONB?
Product code ONB, “Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System” in FDA's classification database, is a Class II device type under 21 CFR 880.5440 (intravascular administration set), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 41 clearances under ONB, 41 of them since 2011.
How many 510(k) clearances are there under ONB?
FDA’s 510(k) database listed 41 clearances under ONB as of Oct 29, 2026, 41 of them decided since 2011; the most recent decision was Dec 5, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a ONB 510(k)?
For the 7 ONB clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 90 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most ONB clearances?
Since 2011: Epic Medical Pte. , Ltd. (12), Simplivia Healthcare , Ltd. (6), Becton, Dickinson and Company (4), Equashield Medical , Ltd. (4) and Icu Medical, Inc. (3). 13 applicants have cleared a ONB device in that time.